CASI Pharmaceuticals competitors

CASI Pharmaceuticals's competitors include Neos Therapeutics, RespireRx Pharmaceuticals, Akorn and Daiichi Sankyo
Add company...
CASI Pharmaceuticals
CASI Pharmaceuticals focuses on building a pipeline through mutually beneficial business development transactions.
Neos Therapeutics
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
RespireRx Pharmaceuticals
RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.
Akorn
Akorn is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products.
Daiichi Sankyo
Daiichi Sankyo develops and markets pharmaceuticals.
Founding Date
Founding Date
1991
Founding Date
2008
Founding Date
1988
Founding Date
1948
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Rockville, US HQ
Beijing, CN
Locations
Grand Prairie, US HQ
Blue Bell, US
Locations
Glen Rock, US HQ
Locations
Lake Forest, US HQ
Gurugram, IN
Jersey, JE
Brooklyn, US
Queens, US
Houston, US
Ann Arbor, US
Locations
Parsippany-Troy Hills, US HQ
Employees
Employees
2630% increase
Employees
134
Employees
1
Employees
2,261
Employees
3,168
Valuation ($)
Valuation ($)
485 m
Valuation ($)
197.2 m
Valuation ($)
2.3 m
Valuation ($)
1.9 b
Valuation ($)
14.7 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$9.2m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$841m (FY, 2017)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$11.4m (FY, 2016)
Cost of goods
N/A
Cost of goods
$407.9m (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
($2.3m) (FY, 2016)
Gross profit
N/A
Gross profit
$433.1m (FY, 2017)
Gross profit
N/A
Net income
Net income
($9.5m) (FY, 2016)
Net income
($83.3m) (FY, 2016)
Net income
($4.3m) (FY, 2017)
Net income
($24.6m) (FY, 2017)
Net income
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Neos Therapeutics
HQ
Grand Prairie, US
Employees
134

Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.

View company
RespireRx Pharmaceuticals
HQ
Glen Rock, US
Employees
1

RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.

View company
Akorn
HQ
Lake Forest, US
Employees
2,261

Akorn is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products.

View company
Daiichi Sankyo
HQ
Parsippany-Troy Hills, US
Employees
3,168

Daiichi Sankyo develops and markets pharmaceuticals.

View company